Market Overview:
The global blood grouping analyzer market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for blood grouping analyzers due to the rising prevalence of blood disorders and increasing number of transfusions. In addition, technological advancements in blood grouping analyzers are also contributing to the growth of this market. On the basis of type, the global blood grouping analyzer market is segmented into fully automated and semi-automated types. The fully automated type is expected to dominate this market during the forecast period owing to its advantages such as accuracy and speed over semi-automated types. On the basis of application, hospitals are expected to account for a major share of this market duringthe forecast period owingto their large patient population base and growing demand for accurate diagnosisand treatment options for various diseases including cancer, heart disease, etc.
Product Definition:
A blood grouping analyzer is a medical device used to determine a person's blood type. The device works by isolating white blood cells from a sample of the patient's blood and then performing an antigen test on the cells. This test looks for proteins that are present on the surface of red blood cells and that can be used to identify someone's specific blood type.
Fully Automated Blood Grouping Analyzer:
FABGA is fully automated, it can analyze up to 1000 samples per hour and has the capacity to process about 100000 samples in a day. It's usage in FABGAR market is increasing due to its benefits such as high speed, accuracy and reliability.
Blood grouping analyzers are used for testing of blood for compatibility between donor and recipient.
Semi Automated Blood Grouping Analyzer:
Semi-automated blood grouping analyzer is a device that helps in analyzing the blood group of an individual by comparing it with known groups. It also helps to identify rare groups and outgroups. The major advantage of using this device over other devices used for blood grouping is that it only requires one set of samples (one unit of sample) instead of many sets as in case of other devices, which reduces the overall cost incurred and also improves efficiency.
Application Insights:
The hospital application segment dominated the global blood grouping analyzer market in 2017. This can be attributed to factors such as rising prevalence of chronic diseases and increasing number of surgeries. For instance, according to the World Health Organization (WHO), around 1 in 6 deaths occur due to cancer. Globally, around 2 million people die due to this disease every year and it is expected that by 2030, about 3 million will die due to cancer if action is not taken against this disease now. Hence, demand for advanced diagnostic tests has increased which eventually led hospitals across the world adopting automated blood grouping analyzers for their laboratories so that they can provide faster results with higher accuracy compared to manual methods used till date.
Blood banks are anticipatedto grow at a lucrative rate over the forecast period owingto increasein transfusion activities across various regions coupled with growing awareness regarding preservation of donor¢â‚¬â„¢s stem cells.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of companies, which have been developing advanced automated devices for blood grouping analysis. The U.S.-based company Thermo Fisher Scientific has developed COVID-19 rapid and easy-to-use diagnostic test, which is based on blood grouping technology called flow cytometry’s fluorescence-based technique that uses antibodies against specific antigens to identify different human groups and is used for rapid diagnosis of COVID 19 infections in this region (Asia Pacific).
The Asia Pacific regional market held a significant share due to increasing awareness about various infectious diseases among people as well as high unmet needs regarding transfusion procedures in this region. Moreover, growing healthcare expenditure by countries such as China and India are expected to fuel the demand for technologically advanced medical products including automated analyzers over the forecast period in this region.
Growth Factors:
- Increasing demand for blood grouping and compatibility testing owing to rising prevalence of blood disorders and increasing number of transfusions
- Technological advancements in blood grouping analyzers that offer enhanced accuracy, speed, and efficiency
- Growing number of private diagnostic laboratories that offer blood grouping services
- Rising awareness about the benefits of early diagnosis and treatment of blood disorders
- Increasing funding for research on novel methods for accurate detection of rareblood groups
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Grouping Analyzer Market Research Report
By Type
Fully Automated Blood Grouping Analyzer, Semi Automated Blood Grouping Analyzer
By Application
Hospital, Blood Bank
By Companies
Beijing Strong Biotechnologies, Inc., Grifols, Ortho Clinical Diagnostics, Quotient, Immucor, Beckman Coulter (Danaher), Aikang Medtech, Suzhou Hybiome Biomedical Engineering Co. Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
167
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Blood Grouping Analyzer Market Report Segments:
The global Blood Grouping Analyzer market is segmented on the basis of:
Types
Fully Automated Blood Grouping Analyzer, Semi Automated Blood Grouping Analyzer
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Blood Bank
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Beijing Strong Biotechnologies, Inc.
- Grifols
- Ortho Clinical Diagnostics
- Quotient
- Immucor
- Beckman Coulter (Danaher)
- Aikang Medtech
- Suzhou Hybiome Biomedical Engineering Co. Ltd
Highlights of The Blood Grouping Analyzer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fully Automated Blood Grouping Analyzer
- Semi Automated Blood Grouping Analyzer
- By Application:
- Hospital
- Blood Bank
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Grouping Analyzer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Blood Grouping Analyzer is a computer program that can determine the blood group of a person.
Some of the major companies in the blood grouping analyzer market are Beijing Strong Biotechnologies, Inc., Grifols, Ortho Clinical Diagnostics, Quotient, Immucor, Beckman Coulter (Danaher), Aikang Medtech, Suzhou Hybiome Biomedical Engineering Co. Ltd.
The blood grouping analyzer market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blood Grouping Analyzer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Blood Grouping Analyzer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Blood Grouping Analyzer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Blood Grouping Analyzer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Blood Grouping Analyzer Market Size & Forecast, 2018-2028
4.5.1 Blood Grouping Analyzer Market Size and Y-o-Y Growth
4.5.2 Blood Grouping Analyzer Market Absolute $ Opportunity
Chapter 5 Global Blood Grouping Analyzer Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Blood Grouping Analyzer Market Size Forecast by Type
5.2.1 Fully Automated Blood Grouping Analyzer
5.2.2 Semi Automated Blood Grouping Analyzer
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Blood Grouping Analyzer Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Blood Grouping Analyzer Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Blood Bank
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Blood Grouping Analyzer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Blood Grouping Analyzer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Blood Grouping Analyzer Analysis and Forecast
9.1 Introduction
9.2 North America Blood Grouping Analyzer Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Blood Grouping Analyzer Market Size Forecast by Type
9.6.1 Fully Automated Blood Grouping Analyzer
9.6.2 Semi Automated Blood Grouping Analyzer
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Blood Grouping Analyzer Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Blood Bank
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Blood Grouping Analyzer Analysis and Forecast
10.1 Introduction
10.2 Europe Blood Grouping Analyzer Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Blood Grouping Analyzer Market Size Forecast by Type
10.6.1 Fully Automated Blood Grouping Analyzer
10.6.2 Semi Automated Blood Grouping Analyzer
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Blood Grouping Analyzer Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Blood Bank
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Blood Grouping Analyzer Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Blood Grouping Analyzer Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Blood Grouping Analyzer Market Size Forecast by Type
11.6.1 Fully Automated Blood Grouping Analyzer
11.6.2 Semi Automated Blood Grouping Analyzer
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Blood Grouping Analyzer Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Blood Bank
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Blood Grouping Analyzer Analysis and Forecast
12.1 Introduction
12.2 Latin America Blood Grouping Analyzer Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Blood Grouping Analyzer Market Size Forecast by Type
12.6.1 Fully Automated Blood Grouping Analyzer
12.6.2 Semi Automated Blood Grouping Analyzer
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Blood Grouping Analyzer Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Blood Bank
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Blood Grouping Analyzer Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Blood Grouping Analyzer Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Blood Grouping Analyzer Market Size Forecast by Type
13.6.1 Fully Automated Blood Grouping Analyzer
13.6.2 Semi Automated Blood Grouping Analyzer
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Blood Grouping Analyzer Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Blood Bank
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Blood Grouping Analyzer Market: Competitive Dashboard
14.2 Global Blood Grouping Analyzer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Beijing Strong Biotechnologies, Inc.
14.3.2 Grifols
14.3.3 Ortho Clinical Diagnostics
14.3.4 Quotient
14.3.5 Immucor
14.3.6 Beckman Coulter (Danaher)
14.3.7 Aikang Medtech
14.3.8 Suzhou Hybiome Biomedical Engineering Co. Ltd
